Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 152
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Sci Rep ; 9(1): 10925, 2019 07 29.
Artículo en Inglés | MEDLINE | ID: mdl-31358768

RESUMEN

Trace amines such as p-tyramine, p-octopamine and p-synephrine are found in low concentrations in animals and plants. Consumption of pre-workout supplements containing these plant-derived amines has been associated with cardiovascular side effects. The aim of this study was to determine the mechanisms of action of these trace amines on porcine isolated coronary and mesenteric arteries. Noradrenaline caused contraction of mesenteric arteries and relaxation of coronary arteries. In both tissues, all three trace amines induced contractions with similar potencies and responses were unaffected by the ß-adrenoceptor antagonist propranolol (1 µM), the nitric oxide synthase inhibitor L-NNA (100 µM), or the TAAR-1 antagonist, EPPTB (100 nM). However, the contractile responses of mesenteric arteries, but not coronary arteries, were significantly reduced by depletion of endogenous noradrenaline. Mesenteric responses to all three amines were abolished in the presence of prazosin (1 µM) whereas residual contractile responses remained in the coronary artery which were inhibited by a high concentration (100 µM) of EPPTB. The results suggest complex responses of the coronary artery to the trace amines, with activity at α1-adrenoceptors and potentially TAARs other than TAAR-1. In contrast the actions of the amines on the mesenteric artery appeared to involve indirect sympathomimetic actions and direct actions on α1-adrenoceptors.


Asunto(s)
Agonistas alfa-Adrenérgicos/farmacología , Vasos Coronarios/efectos de los fármacos , Arterias Mesentéricas/efectos de los fármacos , Octopamina/farmacología , Sinefrina/farmacología , Tiramina/farmacología , Vasoconstrictores/farmacología , Animales , Benzamidas/farmacología , Vasos Coronarios/fisiología , Femenino , Arterias Mesentéricas/fisiología , Nitroarginina/farmacología , Propranolol/farmacología , Pirrolidinas/farmacología , Porcinos , Vasodilatación , Vasodilatadores/farmacología
2.
Phytomedicine ; 53: 163-170, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30668395

RESUMEN

BACKGROUND: Zanthoxylum armatum DC (Z. armatum), belonging to Rutaceae family, has been traditionally used for the treatment of various diseases such as hypertension, abdominal pain, headache, fever, high altitude sickness, diarrhea, dysentery, and as a tonic, condiment, and an anthelmintic treatment. HYPOTHESIS: The present study aims to evaluate the vasorelaxant effect of a methanolic extract of the fruits of Z. armatum, isolate the active components and characterize the underlying mechanism. STUDY DESIGN: A methanolic extract of fruits of Z. armatum was prepared and its vasorelaxant effect was studied using porcine coronary artery rings. Thereafter, the methanolic extract was analyzed, and a major compound was isolated and its structure elucidated (tambulin). Different pharmacological tools were used to characterize the vasorelaxant effect of tambulin. RESULTS: The methanolic extract and the isolated tambulin caused similar endothelium-independent relaxations of porcine coronary artery rings with and without endothelium indicating a direct relaxing effect at the vascular smooth muscle. Tambulin did not affect the relaxation curves to the endothelium-dependent vasodilators, bradykinin and the calcium ionophore A23187 in rings with endothelium. Tambulin (1 µM) slightly but significantly shifted leftwards the concentration-relaxation curve to the endothelium-independent vasodilators, sodium nitroprusside (SNP), forskolin (FC) and isoproterenol but not those to soluble guanylyl cyclase activators (YC-1 and BAY 41-2272) and K+ channel openers (levcromakalim and 1-EBIO). Pretreatment with tambulin inhibited, in a concentration-dependent manner, contractions to KCl, serotonin (5-HT), CaCl2 and U46619 in coronary artery rings without endothelium. Both the protein kinase A (H-89, 10 µM) and the protein kinase G (Rp-8-br-cyclic GMPS, 30 µM) inhibitors significantly reduced relaxations to tambulin in coronary artery rings without endothelium. CONCLUSION: The present findings indicate that tambulin isolated from Z. armatum (fruits) is a major active principle inducing vasorelaxation through a direct effect at the vascular smooth muscle and involving both the cyclic AMP and/or cyclic GMP relaxing pathways.


Asunto(s)
Benzopiranos/farmacología , Vasos Coronarios/efectos de los fármacos , AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Vasodilatadores/farmacología , Zanthoxylum/química , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/farmacología , Animales , Benzopiranos/química , Bradiquinina/farmacología , Vasos Coronarios/metabolismo , Vasos Coronarios/fisiología , Relación Dosis-Respuesta a Droga , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Frutas/química , Metanol/química , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , Nitroprusiato/farmacología , Técnicas de Cultivo de Órganos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Porcinos , Vasodilatación/efectos de los fármacos , Vasodilatadores/administración & dosificación , Vasodilatadores/química , Vasodilatadores/aislamiento & purificación
3.
J Ethnopharmacol ; 225: 211-219, 2018 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-30009977

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Thymus linearis, Benth indigenous to Pakistan has been traditionally used for the treatment of various diseases including hypertension. AIM OF THE STUDY: Present study aims to investigate vasorelaxant effect of Thymus linearis and its underlying vasorelaxation mechanisms in porcine coronary artery rings. MATERIALS AND METHODS: Aqueous-methanolic extract of aerial parts of Thymus linearis was prepared by maceration process and then bio-guided fractionation was carried out using different solvents. The effects of extract and subsequent fractions were assessed on coronary artery rings with intact and denuded endothelium. The mechanisms of vasorelaxant effect were investigated using different pharmacological tools. The in-vitro inhibitory effects of the test fractions were also assessed on purified phophodiestrases using radioenzymatic assay. Phytochemical studies were carried out using GCMS. RESULTS: The aqueous-methanolic extract elicited similar relaxations in coronary artery rings with and without endothelium in dose dependent fashion and removal of endothelium did not alter this response. Further, n-butanolic fraction of Thymus liniaris (TLB) was found to be the most potent among other derived fractions. TLB did not alter the relaxation produced by endothelium dependent vasodilators in rings with intact endothelium. However, TLB significantly potentiated the relaxation elicited by cyclic AMP and cyclic GMP elevating drugs but not those to soluble guanylyl cyclase activators (YC-1 and BAY 41-2272) and K+ channel openers (levcromakalim and 1-EBIO). Pretreatment with TLB inhibited in a concentration-dependent manner contractions to KCl, CaCl2 and U46619 in coronary artery rings without endothelium. Further, TLB was found to non-selectively inhibit the PDE activity in concentration manner. CONCLUSION: n-Butanolic fraction of Thymus linearis possesses endothelium independent vasorelaxant effects in coronary artery by direct acting on the smooth muscles. These effects involve the elevation of the cyclic AMP and cyclic GMP possibly through the inhibition of various PDEs. GCMS analysis revel presence of thymole and carvacrol as major constituents. Furthermore, these investigations also support the folklore use of Thymus linearis in hypertension.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Extractos Vegetales/farmacología , Thymus (Planta) , Vasodilatadores/farmacología , 1-Butanol/química , Acetatos/química , Animales , Vasos Coronarios/fisiología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Técnicas In Vitro , Metanol/química , Componentes Aéreos de las Plantas , Extractos Vegetales/análisis , Polifenoles/análisis , Polifenoles/farmacología , Solventes/química , Porcinos , Vasodilatación/efectos de los fármacos , Vasodilatadores/análisis
4.
Eur J Pharmacol ; 826: 96-105, 2018 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-29501863

RESUMEN

The pharmacological activity of DSP-6952, a novel compound was investigated, compared to that of clinically efficacious gastrointestinal (GI) prokinetic 5-hydroxytryptamine4 (5-HT4) receptor agonists. DSP-6952 had a strong affinity of Ki = 51.9 nM for 5-HT4(b) receptor, and produced contraction in the isolated guinea pig colon with EC50 of 271.6 nM and low intrinsic activity of 57%, similar to tegaserod and mosapride. In the development of the 5-HT4 receptor agonists, cardiovascular risk was deliberately evaluated, because some related prokinetics were reported to cause with cardiovascular adverse events, such as ventricular arrhythmias or ischemia. DSP-6952 showed minimal effects up to 100 µM in human ether-a-go-go-related gene (hERG) channels or guinea pig cardiomyocytes. In telemetered conscious monkeys, DSP-6952 did not affect blood pressure or any electrocardiogram (ECG) up to 180 mg/kg, p.o.; however, DSP-6952 transiently increased heart rate, as well as in anesthetized dogs. The positive chronotropic effects of DSP-6952 were completely antagonized by a 5-HT4 receptor antagonist, and another 5-HT4 receptor agonist, TD-5108 also increased heart rate. These effects are considered a class effect seen in clinically developing and marketed 5-HT4 receptor agonists, and have not been regarded as a critical issue in clinical use. DSP-6952 did not induce contraction in the rabbit coronary artery up to 100 µM, which differed from tegaserod or sumatriptan. These results show that DSP-6952 does not have cardiac ischemic risk via coronary vasoconstriction. In conclusion, DSP-6952 is a promising GI prokinetic compound with partial 5-HT4 receptor agonistic activity as well as a favorable cardiovascular safety profile.


Asunto(s)
Sistema Cardiovascular/efectos de los fármacos , Vasos Coronarios/efectos de los fármacos , Canales de Potasio Éter-A-Go-Go/metabolismo , Morfolinas/farmacología , Piperidinas/farmacología , Agonistas del Receptor de Serotonina 5-HT4/farmacología , Animales , Compuestos de Azabiciclo/farmacología , Benzamidas/farmacología , Cisaprida/farmacología , Colon/efectos de los fármacos , Colon/metabolismo , Vasos Coronarios/fisiología , Perros , Evaluación Preclínica de Medicamentos/métodos , Cobayas , Humanos , Indoles/farmacología , Macaca fascicularis , Masculino , Contracción Muscular/efectos de los fármacos , Miocitos Cardíacos , Técnicas de Placa-Clamp , Conejos , Receptores de Serotonina 5-HT4/metabolismo , Sumatriptán/farmacología
5.
Int J Mol Med ; 41(4): 2420-2428, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29328426

RESUMEN

Ginger (Zingiber officinale Roscoe) is a popular Chinese herbal medicine, which is considered to warm the stomach and dispel cold in traditional Chinese medicine. Ginger is widely used to treat stomach disorders, and it has been reported to exhibit antithrombotic activity via the inhibition of platelet aggregation and thromboxane B2 production in vitro. Cardiovascular disease is associated with the aberrant functioning of the heart and circulatory system; the relatively narrow vessels of the circulation are commonly affected and blocked by atherosclerosis, which may result in angina or heart attack. Numerous drugs and medicines are used to treat myocardial infarction; however, they are often associated with numerous side effects. Therefore, it is important to identify substitutive drugs with no unbearable side effects. In the present study, the relaxant effects of ginger crude extract (GCE) were determined on porcine coronary arteries. The DPPH radical scavenging assay, lucigenin­enhanced chemiluminescence assay and western blot analysis were used to individually detect antioxidant assay of ginger extraction or superoxide anion produced by endothelial cells and molecular signaling. The results indicated that GCE induced relaxation of porcine coronary arteries in an endothelium­dependent manner. GCE increased vasoprotection via the suppression of nitric oxide synthase and cyclooxygenase. In addition, GCE possessed antioxidant ability, as determined using 1,1­diphenyl­2­picrylhydrazyl and lucigenin­enhanced chemiluminescence assays. Taken together, the present study demonstrated that GCE exerts marked vasoprotective effects and free radical­scavenging activities in porcine coronary arteries.


Asunto(s)
Antioxidantes/farmacología , Vasos Coronarios/efectos de los fármacos , Extractos Vegetales/farmacología , Vasodilatadores/farmacología , Zingiber officinale/química , Animales , Antioxidantes/química , Compuestos de Bifenilo/metabolismo , Vasos Coronarios/fisiología , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa/metabolismo , Picratos/metabolismo , Extractos Vegetales/química , Transducción de Señal/efectos de los fármacos , Guanilil Ciclasa Soluble/metabolismo , Porcinos , Vasodilatadores/química
6.
Eur J Pharmacol ; 815: 26-32, 2017 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-28989085

RESUMEN

Ferulic acid, a natural ingredient presents in several Chinese Materia Medica such as Radix Angelicae Sinensis, has been identified as an important multifunctional and physiologically active small molecule. However, its pharmacological activity in different blood vessel types and underlying mechanisms are unclear. The present study was to investigate the vascular reactivity and the possible action mechanism of FA on aorta, small mesenteric arteries and coronary arteries isolated from Wistar rats. We found FA dose-dependently relieved the contraction of aorta, small mesenteric arteries and coronary arteries induced by different contractors, U46619, phenylephrine (Phe) and KCl. The relaxant effect of FA was not affected by L-NAME (eNOS inhibitor), ODQ (soluble guanylate cyclase inhibitor), and mechanical removal of endothelium in thoracic aortas. The contraction caused by 60mM KCl (60K) was concentration-dependently hindered by FA pretreatment in all three types of arteries. In Ca2+-free 60K solution, FA weakened Ca2+-related contraction in a concentration dependent manner. And FA relaxed both fluoride and phorbol ester which were PKC, ERK and Rho-kinase activators induced contraction in aortic rings with or without Ca2+ in krebs solution. Western blotting experiments in A7r5 cells revealed that FA inhibited calcium sensitization via dephosphorylation of ERK1/2 and MYPT1. Furthermore, the relaxation effect of FA was attenuated by verapamil (calcium channel blocker), ERK inhibitor, and fasudil (ROCK inhibitor). These results provide evidence that FA exhibits endothelium-independent vascular relaxant effect in different types of arteries. The molecular mechanism of vasorelaxation activity of FA probably involved calcium channel inhibition and calcium desensitization.


Asunto(s)
Aorta/efectos de los fármacos , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio/metabolismo , Calcio/farmacología , Vasos Coronarios/efectos de los fármacos , Ácidos Cumáricos/farmacología , Arterias Mesentéricas/efectos de los fármacos , Animales , Aorta/metabolismo , Aorta/fisiología , Línea Celular , Vasos Coronarios/metabolismo , Vasos Coronarios/fisiología , Relación Dosis-Respuesta a Droga , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Masculino , Arterias Mesentéricas/metabolismo , Arterias Mesentéricas/fisiología , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/antagonistas & inhibidores , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico/metabolismo , Fosforilación/efectos de los fármacos , Proteína Fosfatasa 1/metabolismo , Ratas , Ratas Wistar , Vasoconstricción/efectos de los fármacos , Vasodilatación/efectos de los fármacos , Quinasas Asociadas a rho/antagonistas & inhibidores
7.
Biogerontology ; 18(2): 217-236, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28039570

RESUMEN

Recent evidence suggests that high dose and/or long term use of proton pump inhibitors (PPIs) may increase the risk of adverse cardiovascular events in older patients, but mechanisms underlying these detrimental effects are not known. Taking into account that the senescent endothelial cells have been implicated in the genesis or promotion of age-related cardiovascular disease, we hypothesized an active role of PPIs in senescent cells. The aim of this study is to investigate the changes in gene expression occurring in senescent and non-senescent human coronary artery endothelial cells (HCAECs) following Omeprazole (OPZ) or Lansoprazole (LPZ) treatment. Here, we show that atherogenic response is among the most regulated processes in PPI-treated HCAECs. PPIs induced down-regulation of anti-atherogenic chemokines (CXCL11, CXCL12 and CX3CL1) in senescent but not in non-senescent cells, while the same chemokines were up-regulated in untreated senescent cells. These findings support the hypothesis that up-regulated anti-atherogenic chemokines may represent a defensive mechanism against atherosclerosis during cellular senescence, and suggest that PPIs could activate pro-atherogenic pathways by changing the secretory phenotype of senescent HCAECs. Moreover, the genes coding for fatty acid binding protein 4 (FABP4) and piezo-type mechanosensitive ion channel component 2 (PIEZO2) were modulated by PPIs treatment with respect to untreated cells. In conclusions, our results show that long-term and high dose use of PPI could change the secretory phenotype of senescent cells, suggesting one of the potential mechanisms by which use of PPI can increase adverse outcomes in older subjects.


Asunto(s)
Senescencia Celular/fisiología , Vasos Coronarios/fisiología , Células Endoteliales/fisiología , Lansoprazol/administración & dosificación , Omeprazol/administración & dosificación , Transcriptoma/fisiología , Células Cultivadas , Senescencia Celular/efectos de los fármacos , Vasos Coronarios/citología , Vasos Coronarios/efectos de los fármacos , Citocinas/metabolismo , Relación Dosis-Respuesta a Droga , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/fisiología , Humanos , Inhibidores de la Bomba de Protones/administración & dosificación , Activación Transcripcional/efectos de los fármacos , Activación Transcripcional/fisiología , Transcriptoma/efectos de los fármacos
8.
PLoS One ; 11(10): e0164524, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27741282

RESUMEN

BACKGROUND: Breathing maneuvers can elicit a similar vascular response as vasodilatory agents like adenosine; yet, their potential diagnostic utility in the presence of coronary artery stenosis is unknown. The objective of the study is to investigate if breathing maneuvers can non-invasively detect inducible ischemia in an experimental animal model when the myocardium is imaged with oxygenation-sensitive cardiovascular magnetic resonance (OS-CMR). METHODS AND FINDINGS: In 11 anesthetised swine with experimentally induced significant stenosis (fractional flow reserve <0.75) of the left anterior descending coronary artery (LAD) and 9 control animals, OS-CMR at 3T was performed during two different breathing maneuvers, a long breath-hold; and a combined maneuver of 60s of hyperventilation followed by a long breath-hold. The resulting change of myocardial oxygenation was compared to the invasive measurements of coronary blood flow, blood gases, and oxygen extraction. In control animals, all breathing maneuvers could significantly alter coronary blood flow as hyperventilation decreased coronary blood flow by 34±23%. A long breath-hold alone led to an increase of 97±88%, while the increase was 346±327% (p<0.001), when the long breath-hold was performed after hyperventilation. In stenosis animals, the coronary blood flow response was attenuated after both hyperventilation and the following breath-hold. This was matched by the observed oxygenation response as breath-holds following hyperventilation consistently yielded a significant difference in the signal of the MRI images between the perfusion territory of the stenosis LAD and remote myocardium. There was no difference between the coronary territories during the other breathing maneuvers or in the control group at any point. CONCLUSION: In an experimental animal model, the response to a combined breathing maneuver of hyperventilation with subsequent breath-holding is blunted in myocardium subject to significant coronary artery stenosis. This maneuver may allow for detecting severe coronary artery stenosis and have a significant clinical potential as a non-pharmacological method for diagnostic testing in patients with suspected coronary artery disease.


Asunto(s)
Adenosina/administración & dosificación , Estenosis Coronaria/diagnóstico por imagen , Imagen por Resonancia Cinemagnética , Vasodilatadores/administración & dosificación , Animales , Análisis de los Gases de la Sangre , Ejercicios Respiratorios/métodos , Angiografía Coronaria , Estenosis Coronaria/tratamiento farmacológico , Estenosis Coronaria/fisiopatología , Vasos Coronarios/diagnóstico por imagen , Vasos Coronarios/fisiología , Modelos Animales de Enfermedad , Fluoroscopía , Hiperventilación/fisiopatología , Miocardio/metabolismo , Oxígeno/sangre , Oxígeno/metabolismo , Consumo de Oxígeno , Porcinos
9.
Zhongguo Zhen Jiu ; 36(1): 48-52, 2016 Jan.
Artículo en Chino | MEDLINE | ID: mdl-26946735

RESUMEN

OBJECTIVE: To compare the effects between slow twisting needle insertion and tubing needle insertion. METHODS: With cross-over design, 100 healthy young subjects (half male and half female) aged from 19 to 23 years were randomly divided into two groups by random digital table, 50 cases in each one. At the first stage, subjects in the group A were treated with slow twisting needle insertion while, subjects in,the group B were treated with tubing needle insertion. One week later, the procedure of second stage was performed alternately. The needle was inserted into Neiguan (PC 6) with two methods by one acupuncturist. The needle was retained for 5 min before removal. Five min before needle insertion as well as needle withdrawal and 30 min after needle withdrawal, ZXG-E automatic cardiovascular diagnostic apparatus was used to test cardiovascular function. RESULTS: At the tim of needle withdrawal, slow twisting needle insertion could improve effect work of kinetics (EWK), effective blood volume (BV) and reduce elastic expansion coefficient of blood vessel (FEK) and left ventricular spray blood impedance (VER), which was significantly different from tubing needle insertion (all P < 0.05). Thirty min after needle withdrawal, the differences of the indices of cardiovascular function between the two groups were not significant (all P > 0.05). CONCLUSION: The slow twisting needle insertion is significantly superior to tubing needle insertion on lowering vascular tension and VER, improving EWK and BV.


Asunto(s)
Puntos de Acupuntura , Terapia por Acupuntura/métodos , Vasos Coronarios/fisiología , Función Ventricular , Terapia por Acupuntura/instrumentación , Circulación Sanguínea , Volumen Sanguíneo , Femenino , Humanos , Masculino , Agujas , Adulto Joven
10.
Br J Pharmacol ; 173(5): 870-87, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26660275

RESUMEN

BACKGROUND AND PURPOSE: We investigated the hypothesis that elevated glucose increases contractile responses in vascular smooth muscle and that this enhanced constriction occurs due to the glucose-induced PKC-dependent inhibition of voltage-gated potassium channels. EXPERIMENTAL APPROACH: Patch-clamp electrophysiology in rat isolated mesenteric arterial myocytes was performed to investigate the glucose-induced inhibition of voltage-gated potassium (Kv ) current. To determine the effects of glucose in whole vessel, wire myography was performed in rat mesenteric, porcine coronary and human internal mammary arteries. KEY RESULTS: Glucose-induced inhibition of Kv was PKC-dependent and could be pharmacologically dissected using PKC isoenzyme-specific inhibitors to reveal a PKCß-dependent component of Kv inhibition dominating between 0 and 10 mM glucose with an additional PKCα-dependent component becoming evident at concentrations greater than 10 mM. These findings were supported using wire myography in all artery types used, where contractile responses to vessel depolarization and vasoconstrictors were enhanced by increasing bathing glucose concentration, again with evidence for distinct and complementary PKCα/PKCß-mediated components. CONCLUSIONS AND IMPLICATIONS: Our results provide compelling evidence that glucose-induced PKCα/PKCß-mediated inhibition of Kv current in vascular smooth muscle causes an enhanced constrictor response. Inhibition of Kv current causes a significant depolarization of vascular myocytes leading to marked vasoconstriction. The PKC dependence of this enhanced constrictor response may present a potential therapeutic target for improving microvascular perfusion following percutaneous coronary intervention after myocardial infarction in hyperglycaemic patients.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Glucosa/farmacología , Arterias Mamarias/efectos de los fármacos , Arterias Mesentéricas/efectos de los fármacos , Proteína Quinasa C beta/fisiología , Proteína Quinasa C-alfa/fisiología , Animales , Vasos Coronarios/fisiología , Humanos , Técnicas In Vitro , Isoenzimas/antagonistas & inhibidores , Isoenzimas/fisiología , Masculino , Arterias Mamarias/fisiología , Arterias Mesentéricas/fisiología , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/fisiología , Canales de Potasio con Entrada de Voltaje/fisiología , Proteína Quinasa C beta/antagonistas & inhibidores , Proteína Quinasa C-alfa/antagonistas & inhibidores , Ratas Wistar , Porcinos , Vasoconstricción/efectos de los fármacos
11.
Oxid Med Cell Longev ; 2015: 6309565, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26697138

RESUMEN

Camellia japonica is a popular garden plant in Asia and widely used as cosmetic sources and traditional medicine. However, the possibility that C. japonica affects cardiovascular system remains unclear. The aim of the present study was to evaluate vascular effects of an extract of C. japonica. Vascular reactivity was assessed in organ baths using porcine coronary arteries and inhibition of proliferation and migration were assessed using human vascular smooth muscle cells (VSMCs). All four different parts, leaf, stem, flower, and fruits, caused concentration-dependent relaxations and C. japonica fruit (CJF) extract showed the strongest vasorelaxation and its effect was endothelium dependent. Relaxations to CJF were markedly reduced by inhibitor of endothelial nitric oxide synthase (eNOS) and inhibitor of PI3-kinase, but not affected by inhibitor of cyclooxygenase and endothelium-derived hyperpolarizing factor-mediated response. CJF induced activated a time- and concentration-dependent phosphorylation of eNOS in endothelial cells. Altogether, these studies have demonstrated that CJF is a potent endothelium-dependent vasodilator and this effect was involved in, at least in part, PI3K-eNOS-NO pathway. Moreover, CJF attenuated TNF-α induced proliferation and PDGF-BB induced migration of VSMCs. The present findings indicate that CJF could be a valuable candidate of herbal medicine for cardiovascular diseases associated with endothelial dysfunction and atherosclerosis.


Asunto(s)
Camellia/química , Vasos Coronarios/fisiología , Etanol/química , Extractos Vegetales/farmacología , Vasodilatación/efectos de los fármacos , Animales , Camellia/metabolismo , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Frutas/química , Frutas/metabolismo , Humanos , Medicina Tradicional de Asia Oriental , Miocitos del Músculo Liso/citología , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/metabolismo , Óxido Nítrico Sintasa de Tipo III/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación/efectos de los fármacos , Extractos Vegetales/química , Prostaglandina-Endoperóxido Sintasas/química , Prostaglandina-Endoperóxido Sintasas/metabolismo , Porcinos
12.
Circ Cardiovasc Interv ; 8(10): e002928, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26405156

RESUMEN

BACKGROUND: Current guidelines limit the use of high oxygen tension after return of spontaneous circulation after cardiac arrest, focusing on neurological outcome and mortality. Little is known about the impact of hyperoxia on the ischemic heart. Oxygen is frequently administered and is generally expected to be beneficial. This study seeks to assess the effects of hyperoxia on myocardia oxygenation in the presence of severe coronary artery stenosis in swine. METHODS AND RESULTS: In 22 healthy pigs, we surgically attached a magnetic resonance compatible flow probe to the left anterior descending coronary artery (LAD). In 11 pigs, a hydraulic occluder was inflated distal to the flow probe. After increasing PaO2 to >300 mm Hg, LAD flow decreased in all animals. In 8 stenosed animals with a mean fractional flow reserve of 0.64±0.02, hyperoxia resulted in a significant decrease of myocardial signal intensity in oxygenation-sensitive cardiovascular magnetic resonance images of the midapical segments of the LAD territory. This was not seen in remote myocardium or in the other 8 healthy animals. The decreased signal intensity was accompanied by a decrease in circumferential strain in the same segments. Furthermore, ejection fraction, cardiac output, and oxygen extraction ratio declined in these animals. Changing PaCO2 levels did not have a significant effect on any of the parameters; however, hypercapnia seemed to nonsignificantly attenuate the hyperoxia-induced changes. CONCLUSIONS: Ventilation-induced hyperoxia may decrease myocardial oxygenation and lead to ischemia in myocardium subject to severe coronary artery stenosis.


Asunto(s)
Estenosis Coronaria/metabolismo , Vasos Coronarios/fisiología , Oxigenoterapia Hiperbárica , Hiperoxia/metabolismo , Isquemia Miocárdica/metabolismo , Miocardio/metabolismo , Oxígeno/metabolismo , Enfermedad Aguda , Animales , Estenosis Coronaria/complicaciones , Vasos Coronarios/cirugía , Progresión de la Enfermedad , Oxigenoterapia Hiperbárica/efectos adversos , Hiperoxia/complicaciones , Modelos Animales , Isquemia Miocárdica/complicaciones , Porcinos
13.
Transl Res ; 166(1): 44-56, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25514506

RESUMEN

Intake of tomatoes has been linked with healthy diets (eg, Mediterranean diet). However, it remains unknown whether tomato intake exerts protective effects on the vasculature. The aim of this study was to determine whether medium-term supplementation with cooked tomato sauce (CTS) Mediterranean style (sofrito) attenuates diet-induced coronary endothelial dysfunction in an animal model with clinical impact and explore the mechanisms behind the effects. Pigs (N = 18) were fed a 10-day hypercholesterolemic diet. Half of the animals were given a supplement of 100 g/d of CTS (21.5 mg lycopene per day). Coronary responses to escalating doses of vasoactive drugs (acetylcholine, calcium ionophore, and sodium nitroprusside) and L-NG-monomethylarginine (endothelial nitric oxide synthase [eNOS] inhibitor) were measured using flow Doppler. In the coronary arteries, we investigated eNOS gene expression and activation, monocyte chemoattractant protein 1 (MCP-1) expression, and oxidative DNA damage. In the circulation, we investigated lipoprotein resistance to oxidation and the differential proteomic protein profile. In dyslipidemic animals, CTS intake prevented diet-induced impairment of receptor-operated and nonreceptor-operated endothelial-dependent coronary vasodilation. These beneficial effects were associated with enhanced eNOS transcription and activation and diminished DNA damage in the coronary arteries. CTS-fed animals showed lower lipid peroxidation, higher high-density lipoprotein (HDL) antioxidant potential and plasma lycopene levels of 0.16 mg/L. Interestingly, improved HDL functionality was associated with protein profile changes in apolipoprotein A-I and apolipoprotein J. Lipids levels and MCP-1 expression were not affected by CTS. We report that CTS intake protects against low-density lipoprotein-induced coronary endothelial dysfunction by reducing oxidative damage, enhancing eNOS expression and activity, and improving HDL functionality.


Asunto(s)
Apolipoproteína A-I/sangre , Clusterina/sangre , Vasos Coronarios/fisiología , Lipoproteínas HDL/sangre , Solanum lycopersicum , Animales , Colesterol en la Dieta/administración & dosificación , Enfermedad Coronaria/prevención & control , Daño del ADN , Dieta Mediterránea , Endotelio Vascular/fisiología , Femenino , Humanos , Modelos Animales , Óxido Nítrico Sintasa de Tipo III/genética , Óxido Nítrico Sintasa de Tipo III/metabolismo , Estrés Oxidativo , Sus scrofa , Investigación Biomédica Traslacional
14.
Eur J Pharmacol ; 735: 193-201, 2014 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-24751712

RESUMEN

Hesperetin (HSP, one of the most common flavonoids in Citrus) has been reported to possess many benificial effects and is indicated for many diseases both as a therapeutic drug and as a supplement. Although its vascular effects have been extensively studied, little is known about its effects and the underlying mechanisms on coronary artery. In the present study, the myogenic effects of HSP were studied with a wire myograph in isolated rat coronary artery (RCA). Molecular probe and the patch clamp technique were used to study effects of HSP on intracellular free Ca(2+) concentration, inward Ca(2+) currents through L-type voltage-gated Ca(2+) channels (LVGC) and outward K(+) currents through voltage-gated K(+) channels (KV). HSP (0.01-0.1mM) concentration-dependently depressed concentration-contraction curves of both KCl and thromboxane receptor agonist 9,11-Dideoxy-9α,11α-methanoepoxy prostaglandin F2α (U46619), and relaxed RCA precontracted by the both vasoconstrictors. The vasospasmolytic effect was more potent in KCl- than in U46619-induced contraction. The vasorelaxation was attenuated by 4-aminopyridine, a specific KV inhibitor, but not affected by NG-nitro-L-arginine methylester ester, indomethacin, glibenclamide, iberiotoxin, BaCl2 or endothelium denudation. At the same concentrations, HSP inhibited extracellular Ca(2+) influx-induced contraction, reduced intracellular free Ca(2+) concentration, inhibited inward Ca(2+) currents through LVGC and increased outward K(+) currents through KV in the vascular smooth muscle cells (VSMCs) freshly isolated from RCA. Collectively, our results show that HSP is vasospasmolytic in RCA and suggest that the vasospasmolysis is mediated by inhibition of LVGC and enhancement of KV currents in RCA VSMCs.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Hesperidina/farmacología , Miocitos del Músculo Liso/efectos de los fármacos , Canales de Potasio con Entrada de Voltaje/fisiología , Animales , Calcio/metabolismo , Vasos Coronarios/fisiología , Técnicas In Vitro , Masculino , Contracción Miocárdica/efectos de los fármacos , Miocitos del Músculo Liso/fisiología , Ratas Wistar , Vasoconstricción/efectos de los fármacos
15.
PLoS One ; 9(3): e92415, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24662941

RESUMEN

OBJECTIVES: Shen Fu Injection (SF), which consisted of Red ginseng extraction injection (RG) and prepared aconite extraction injection (RA), is a traditional Chinese medicine mainly used for various cardiac diseases. This study is to analyse SF's effects on cardiac performance and coronary circulation. And the coronary dilating effect and mechanism of the above three injections were also explored. METHODS: Mature male guinea pigs were used as our animal model. We employed two types of perfusion methods (constant pressure and constant flow) in vitro, using Langendorff heart preparations to observe the cardiac function and coronary response to SF (1/200). The coronary dilation effects of the above three injections (1/800, 1/400 and 1/200) were recorded at basal coronary resting tone and when coronary vessels were pre-contracted with a thromboxane A2 analogue (U46619), in the presence or the absence of the inhibitor of nitric oxide synthesis (L-NAME, 10-4 M), the blocker of Ca2+-activated potassium channel(TEA, 10-3 M), or the blocker of adenosine triphosphate (ATP)-sensitive potassium channel (glybenclamide) (10-5 M). RESULTS: When perfused with constant pressure, SF significantly increased coronary flow, left ventricular developed pressure (LVDP) and the rate-pressure product (RPP). When perfused with constant flow, SF produced a significant reduction in the coronary perfusion pressure (CPP), LVDP and RPP. The coronary vasodilatation response of the above three injections can be reduced by L-NAME but was unaffected by TEA or glybenclamide when coronary vessels were pre-contracted with U46619 but not at resting tone. SF, RG and RA can all up-regulate eNOS expression in the human umbilical vein cells (EA.hy926). CONCLUSION: We demonstrated that SF does not contribute to the inotropic change of myocardium whose improvement is due to alternation of coronary flow. The coronary dilation effect of SF was mediated through RG and RA, via promoting NO release.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/fisiología , Medicamentos Herbarios Chinos/farmacología , Vasodilatación/efectos de los fármacos , Aconitum/química , Animales , Circulación Coronaria/efectos de los fármacos , Medicamentos Herbarios Chinos/administración & dosificación , Cobayas , Corazón/efectos de los fármacos , Corazón/fisiología , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Inyecciones , Masculino , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo III/metabolismo , Panax/química , Perfusión , Regulación hacia Arriba/efectos de los fármacos
16.
Toxicol Appl Pharmacol ; 272(3): 797-805, 2013 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-23845591

RESUMEN

German chamomile (Matricaria recutita L.), a widely-used herbal medicine, has been reported to have a wide range of biological effects, including smooth muscle relaxation. The aim of this study was to compare the effects of representative compounds from chamomile (apigenin, luteolin, (-)-α-bisabolol, farnesene, umbelliferone; 3-30 µM) on vascular tone using porcine coronary and splenic arteries mounted for isometric tension recording in isolated tissue baths and precontracted with the thromboxane-mimetic U46619. Apigenin, luteolin, and (-)-α-bisabolol produced slow, concentration-dependent relaxations in both the coronary and splenic arteries that were not blocked by inhibition of nitric oxide synthase or potassium channels. Removal of extracellular calcium inhibited the relaxations to all three compounds, and these compounds also inhibited calcium re-addition-evoked contractions, indicating that the relaxation response may be mediated through inhibition of calcium influx. Apigenin and luteolin, but not (-)-α-bisabolol, enhanced the relaxation to the nitric oxide donor sodium nitroprusside, indicating that apigenin and luteolin may act to regulate cyclic GMP levels. Umbelliferone produced a rapid, transient relaxation in the splenic artery, but not the coronary artery, that was inhibited by L-NAME and removal of the endothelium, suggesting an influence on nitric oxide production. Farnesene, at concentrations up to 30 µM, was without effect in either blood vessel. In conclusion, hydroxylated compounds (apigenin, luteolin and (-)-α-bisabolol) found in chamomile all caused a slow relaxation of isolated blood vessels through an effect on calcium influx. Umbelliferone, on the other hand, produced a rapid, transient relaxation dependent upon release of nitric oxide from the endothelium.


Asunto(s)
Manzanilla , Vasos Coronarios/efectos de los fármacos , Extractos Vegetales/farmacología , Arteria Esplénica/efectos de los fármacos , Vasodilatación/efectos de los fármacos , Animales , Vasos Coronarios/fisiología , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , Técnicas de Cultivo de Órganos , Extractos Vegetales/aislamiento & purificación , Arteria Esplénica/fisiología , Porcinos , Vasoconstrictores/farmacología , Vasodilatación/fisiología , Vasodilatadores/farmacología
17.
Fiziol Zh (1994) ; 59(1): 11-6, 2013.
Artículo en Ucraniano | MEDLINE | ID: mdl-23713345

RESUMEN

In experiments on the anaesthetized dogs the influence of a new fluorine-containing opener of ATP-sensitive potassium (K(ATP)) channels flocalin on the cardiohemodynamic of great animals in vivo was studied. Flocalin introduced intravenously in doses 0.01 - 1.5 mgs/kg. It is shown that it reduces in dose-dependent manner a system arterial pressure, perfusion pressure in coronary artery and general peripheral resistance of vessels with maximal effects on 56.8 +/- 2.7, 22.4 +/- 4.7 and 47.2% +/- 6.5% accordingly at most dose 1.5 mgs/kg. Flocalin causes development of cardiodepressive reactions in heart, that is exhibited in dose-dependent the decrease of pressure in the left ventricle, speed of growth (dP/dt(max)) and reduction (dP/dt(min)) in it's of pressure with maximal effects on 37.1 +/- 5.1, 51.2 +/- 9.4 and 55.6% +/- 6.9% accordingly at introduction of most dose of flocalin. Diminish of the cardiac out put and heart rate with a maximal effects on 23.1% +/-12.7% and 19.2% +/- 1.7% accordingly at a dose 1.0 mgs/kg was shown. It should be noted that considerable reduction of heart rate and general peripheral resistance of vessels takes place only at the large doses of flocalin - 1 and 1.5 mgs/kg. Thus, it is shown that activation of K(ATP) channels by flocalin causes the dose-dependent decrease of pressure in the system of circulation of blood and contraction activity of myocardium.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Corazón/efectos de los fármacos , Canales KATP/agonistas , Pinacidilo/análogos & derivados , Animales , Presión Arterial/efectos de los fármacos , Vasos Coronarios/fisiología , Perros , Relación Dosis-Respuesta a Droga , Femenino , Corazón/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Inyecciones Intravenosas , Activación del Canal Iónico/efectos de los fármacos , Activación del Canal Iónico/fisiología , Canales KATP/metabolismo , Masculino , Contracción Miocárdica/efectos de los fármacos , Pinacidilo/farmacología , Resistencia Vascular/efectos de los fármacos , Resistencia Vascular/fisiología , Función Ventricular Izquierda/efectos de los fármacos , Función Ventricular Izquierda/fisiología
18.
Biosci Biotechnol Biochem ; 77(2): 395-7, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23391924

RESUMEN

Bioassay-guided fractionation of the methanol extract from the root of Sophora flavescens led to the isolation of eight known prenylated flavonoids responsible for the vasorelaxation activity in porcine coronary arteries. Among them, kushenol N and 5-methylsophoraflavanone B strongly induced the relaxation of porcine coronary arteries with respective ED(50) values of 8.6 and 12.4 µM. This activity and the results of a high-performance liquid chromatographic analysis suggest that kushenol N and 5-methylsophoraflavanone B could be active markers in the S. flavescens extract for vasorelaxation activity.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Flavonoides/farmacología , Extractos Vegetales/farmacología , Raíces de Plantas/química , Sophora/química , Vasoconstricción , Vasodilatación , Vasodilatadores/farmacología , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/farmacología , Animales , Cromatografía Líquida de Alta Presión , Vasos Coronarios/fisiología , Flavonoides/química , Flavonoides/aislamiento & purificación , Metanol , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Prenilación , Porcinos , Técnicas de Cultivo de Tejidos , Vasoconstrictores/farmacología , Vasodilatadores/química , Vasodilatadores/aislamiento & purificación
19.
Food Funct ; 4(2): 249-57, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23104077

RESUMEN

(-)-Epigallocatechin-3-O-gallate (EGCg) has been shown to induce endothelium-dependent nitric oxide (NO)-mediated relaxation via the redox-sensitive Src/PI3-kinase/Akt-dependent phosphorylation of endothelial NO synthase (eNOS). Although the presence of 8 hydroxyl functions, mainly on B and D rings, is essential for the EGCg-induced activation of eNOS, the relative role of each individual hydroxyl function still remains unclear. This study examined the effect of selective replacement of hydroxyl functions by methoxy moieties on either the B or D ring on the EGCg-induced phosphorylation of Akt and eNOS, formation of reactive oxygen species (ROS) and NO in cultured coronary artery endothelial cells, and endothelium-dependent relaxation of coronary artery rings. Replacement of a single hydroxyl by the methoxy group on position 3', 4' or 4'' affected little the EGCg-induced phosphorylation of Akt and eNOS, formation of ROS and NO in endothelial cells, and induction of endothelium-dependent relaxations. In contrast, the single methylation at position 3'' and the double methylation at both positions 3' and 4' reduced markedly the phosphorylation of Akt and eNOS, the formation of ROS and NO in endothelial cells and the relaxation of artery rings. These findings suggest that the hydroxyl group at the 3'' position of the gallate ring is essential and, also, to some extent, the two hydroxyl groups at positions 3' and 4', for the EGCg-induced redox-sensitive activation of eNOS leading to the subsequent NO-mediated vascular relaxation.


Asunto(s)
Enfermedades Cardiovasculares/enzimología , Catequina/análogos & derivados , Vasos Coronarios/fisiología , Células Endoteliales/enzimología , Óxido Nítrico Sintasa de Tipo III/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Extractos Vegetales/farmacología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Animales , Camellia sinensis/química , Enfermedades Cardiovasculares/genética , Enfermedades Cardiovasculares/fisiopatología , Catequina/química , Catequina/farmacología , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/enzimología , Células Endoteliales/metabolismo , Humanos , Hidroxilación , Técnicas In Vitro , Estructura Molecular , Fosfatidilinositol 3-Quinasas/genética , Fosforilación/efectos de los fármacos , Extractos Vegetales/química , Proteínas Proto-Oncogénicas c-akt/genética , Porcinos , Vasodilatación/efectos de los fármacos
20.
Anesthesiology ; 117(4): 836-46, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22814384

RESUMEN

BACKGROUND: We have recently shown that postischemic administration of intralipid protects the heart against ischemia-reperfusion injury. Here we compared the cardioprotective effects of intralipid with cyclosporine-A, a potent inhibitor of the mitochondrial permeability transition pore opening. METHODS: In vivo rat hearts or isolated Langendorff-perfused mouse hearts were subjected to ischemia followed by reperfusion with intralipid (0.5%, 1% and 2% ex-vivo, and 20% in vivo), cyclosporine-A (0.2 µM, 0.8 µM, and 1.5 µM ex- vivo and 10 mg/kg in vivo), or vehicle. The hemodynamic function, infarct size, calcium retention capacity, mitochondrial superoxide production, and phosphorylation levels of protein kinase B (Akt)/glycogen synthase kinase-3ß (GSK-3ß) were measured. The values are mean ± SEM. RESULTS: Administration of intralipid at reperfusion significantly reduced myocardial infarct size compared with cyclosporine-A in vivo (infarct size/area at risk)%: 22.9 ± 2.5% vs. 35.2 ± 3.5%; P = 0.030, n = 7/group). Postischemic administration of intralipid at its optimal dose (1%) was more effective than cyclosporine-A (0.8 µM) in protecting the ex vivo heart against ischemia-reperfusion injury, as the rate pressure product at the end of reperfusion was significantly higher (mmHg · beats/min: 12,740 ± 675 [n = 7] vs. 9,203 ± 10,781 [n = 5], P = 0.024), and the infarct size was markedly smaller (17.3 ± 2.9 [n = 7] vs. 29.2 ± 2.7 [n = 5], P = 0.014). Intralipid was as efficient as cyclosporine-A in inhibiting the mitochondrial permeability transition pore opening (calcium retention capacity = 280 ± 8.2 vs. 260.3 ± 2.9 nmol/mg mitochondria protein in cyclosporine-A, P = 0.454, n = 6) and in reducing cardiac mitochondrial superoxide production. Unlike intralipid, which increased phosphorylation of Akt (6-fold) and GSK-3ß (5-fold), cyclosporine-A had no effect on the activation of these prosurvival kinases. CONCLUSIONS: Although intralipid inhibits the opening of the mitochondrial permeability transition pore as efficiently as cyclosporine-A, intralipid is more effective in reducing the infarct size and improving the cardiac functional recovery.


Asunto(s)
Cardiotónicos , Ciclosporina/farmacología , Emulsiones Grasas Intravenosas/farmacología , Inmunosupresores/farmacología , Daño por Reperfusión Miocárdica/prevención & control , Fosfolípidos/farmacología , Aceite de Soja/farmacología , Animales , Infarto de la Pared Anterior del Miocardio/patología , Western Blotting , Calcio/metabolismo , Calcio/farmacología , Vasos Coronarios/fisiología , Relación Dosis-Respuesta a Droga , Espectroscopía de Resonancia por Spin del Electrón , Emulsiones/farmacología , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Pruebas de Función Cardíaca , Técnicas In Vitro , Masculino , Ratones , Ratones Endogámicos C57BL , Mitocondrias Cardíacas/efectos de los fármacos , Daño por Reperfusión Miocárdica/patología , Necrosis , Proteína Oncogénica v-akt/metabolismo , Permeabilidad , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/análisis , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA